Recent Finacing
Recent Raise
Senseera develops the GEM BIOMARKERS liquid‑biopsy platform using cfChIP‑seq to decode cell‑specific gene expression from blood for diagnostics and monitoring across oncology, immunology, metabolic and liver diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Senseera.
